{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:59:10Z","timestamp":1789070350678,"version":"build-2803163510"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:00:00Z","timestamp":1375142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic heart failure (CHF), as a progressive clinical syndrome, is characterized by failure of enough blood supply from the heart to meet the body's metabolic demands, and there is intense interest in identifying novel biomarkers that could make contributions to the diagnosis of CHF. Metabolomics, compared with current diagnostic approaches, could investigate many metabolic perturbations within biological systems. The overarching goal of the work discussed here is to apply a high-throughput approach to identify metabolic signatures and plasma diagnostic biomarkers underlying CHF by 1H-NMR spectroscopy. Plasma samples from 39 patients with CHF and 15 controls were analyzed by NMR spectroscopy. After processing the data, orthogonal partial least square discriminant analysis (OPLS-DA) was performed. The statistical model revealed good explained variance and predictability, and the diagnostic performance assessed by leave-one-out analysis exhibited 92.31% sensitivity and 86.67% specificity. The OPLS-DA score plots of spectra revealed good separation between case and control on the level of metabolites, and multiple biochemical changes indicated hyperlipidemia, alteration of energy metabolism and other potential biological mechanisms underlying CHF. It was concluded that the NMR-based metabolomics approach demonstrated good performance to identify diagnostic plasma markers and provided new insights into metabolic process related to CHF.<\/jats:p>\n                  <jats:p\/>","DOI":"10.1039\/c3mb70227h","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T08:52:51Z","timestamp":1375174371000},"page":"2618-2626","source":"Crossref","is-referenced-by-count":79,"title":["Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure"],"prefix":"10.1093","volume":"9","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangtao","family":"Luo","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Chen","sequence":"additional","affiliation":[{"name":"Hangzhou Xiaoshan TCM Hospital b , Zhejiang 311201, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuegong","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhengzhou TCM Hospital c , Zhengzhou 450007, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhengzhou TCM Hospital c , Zhengzhou 450007, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine a , Beijing 100029, China Wangwei@bucm.edu.cn +86-010-64286283 +86-010-64286508"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,7,30]]},"reference":[{"key":"2026012913110996400_cit1","doi-asserted-by":"crossref","first-page":"D57","DOI":"10.1016\/j.ehjsup.2004.05.015","article-title":"Epidemiology and economic burden of chronic heart failure","volume":"6","author":"Bundkirchen","year":"2004","journal-title":"Eur. Heart J. Suppl."},{"issue":"9474","key":"2026012913110996400_cit2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"McMurray","year":"2005","journal-title":"Lancet"},{"key":"2026012913110996400_cit3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0002-8703(00)90311-9","article-title":"et al., Predictors of readmission among elderly survivors of admission with heart failure","volume":"139","author":"Krumholz","year":"2000","journal-title":"Am. Heart J."},{"key":"2026012913110996400_cit4","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008, The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology, developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur. Heart J."},{"key":"2026012913110996400_cit5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","article-title":"The role of metabolites and metabolomics in clinically applicable biomarkers of disease","volume":"85","author":"Mamas","year":"2011","journal-title":"Arch. Toxicol."},{"key":"2026012913110996400_cit6","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1161\/CIRCULATIONAHA.105.569137","article-title":"et al., Metabolomic identification of novel biomarkers of myocardial ischemia","volume":"112","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"2026012913110996400_cit7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.trac.2004.11.021","article-title":"Metabolomics: current analytical platforms and methodologies","volume":"24","author":"Dunn","year":"2005","journal-title":"TrAC, Trends Anal. Chem."},{"key":"2026012913110996400_cit8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11306-007-0063-5","article-title":"et al., Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate","volume":"3","author":"Dunn","year":"2007","journal-title":"Metabolomics"},{"key":"2026012913110996400_cit9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/83496","article-title":"et al., A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations","volume":"19","author":"Raamsdonk","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"2026012913110996400_cit10","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm1202-802","article-title":"et al., Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics","volume":"8","author":"Brindle","year":"2002","journal-title":"Nat. Med."},{"key":"2026012913110996400_cit11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/pr2010082","article-title":"et al., Plasma metabonomics as a novel diagnostic approach for major depressive disorder","volume":"11","author":"Zheng","year":"2012","journal-title":"J. Proteome Res."},{"key":"2026012913110996400_cit12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ac00101a004","article-title":"750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma","volume":"67","author":"Nicholson","year":"1995","journal-title":"Anal. Chem."},{"issue":"supp l","key":"2026012913110996400_cit13","first-page":"S11","article-title":"et al., Urine nuclear magnetic resonance spectroscopy reveals distinct patterns of myocardial substrate metabolism in patients with coronary artery disease (unstable angina pectoris)","author":"Wang","year":"2012","journal-title":"J. Hypertens."},{"key":"2026012913110996400_cit14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/b907021d","article-title":"et al., The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies","volume":"6","author":"Barton","year":"2010","journal-title":"Mol. BioSyst."},{"key":"2026012913110996400_cit15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cem.1006","article-title":"OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification","volume":"20","author":"Bylesj\u00f6","year":"2006","journal-title":"J. Chemom."},{"key":"2026012913110996400_cit16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cem.695","article-title":"Orthogonal projections to latent structures (O-PLS)","volume":"16","author":"Trygg","year":"2002","journal-title":"J. Chemom."},{"key":"2026012913110996400_cit17","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1021\/pr200265z","article-title":"et al., Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis","volume":"10","author":"Amathieu","year":"2011","journal-title":"J. Proteome Res."},{"key":"2026012913110996400_cit18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1074\/mcp.M800165-MCP200","article-title":"et al., Urine metabolomics analysis for kidney cancer detection and biomarker discovery","volume":"8","author":"Kim","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"2026012913110996400_cit19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jhep.2009.11.002","article-title":"et al., A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer","volume":"52","author":"Wen","year":"2010","journal-title":"J. Hepatol."},{"key":"2026012913110996400_cit20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1136\/hrt.72.2_Suppl.S3","article-title":"Changing epidemiological features of cardiac failure","volume":"72","author":"Kannel","year":"1994","journal-title":"Br. Heart J."},{"key":"2026012913110996400_cit21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/leu.2009.295","article-title":"et al., Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups","volume":"24","author":"MacIntyre","year":"2010","journal-title":"Leukemia"},{"key":"2026012913110996400_cit22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cardfail.2011.07.001","article-title":"et al., Molecular Signatures of End-Stage Heart Failure","volume":"17","author":"Lin","year":"2011","journal-title":"J. Card. Failure"},{"key":"2026012913110996400_cit23","first-page":"708","article-title":"Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table","volume":"48","author":"Kumps","year":"2002","journal-title":"Clin. Chem."},{"key":"2026012913110996400_cit24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.yjmcc.2010.07.008","article-title":"et al., Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure","volume":"49","author":"De Souza","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2026012913110996400_cit25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0272-6386(03)00115-X","article-title":"The role of carnitine in myocardial dysfunction","volume":"41","author":"Pauly","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"2026012913110996400_cit26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1253\/circj.72.1359","article-title":"et al., Change in the membranous lipid composition accelerates lipid peroxidation in young rat hearts subjected to 2 weeks of hypoxia followed by hyperoxia","volume":"72","author":"Oka","year":"2008","journal-title":"Circ. J."},{"key":"2026012913110996400_cit27","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.108.816116","article-title":"et al., Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia\/reperfusion","volume":"119","author":"Turer","year":"2009","journal-title":"Circ. J."},{"key":"2026012913110996400_cit28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI115008","article-title":"Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate","volume":"87","author":"Russell","year":"1991","journal-title":"J. Clin. Invest."},{"key":"2026012913110996400_cit29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1074\/mcp.M700394-MCP200","article-title":"et al., Urinary proteomic biomarkers in coronary artery disease","volume":"7","author":"Zimmerli","year":"2008","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Molecular BioSystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/9\/11\/2618\/66153872\/c3mb70227h.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/9\/11\/2618\/66153872\/c3mb70227h.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:16:17Z","timestamp":1769710577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/9\/11\/2618\/8350465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,30]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,7,30]]}},"URL":"https:\/\/doi.org\/10.1039\/c3mb70227h","relation":{},"ISSN":["1742-2051","1742-206X"],"issn-type":[{"value":"1742-2051","type":"electronic"},{"value":"1742-206X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,11,1]]},"published":{"date-parts":[[2013,7,30]]}}}